Grandfield & Dodd LLC maintained its stake in UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, Holdings Channel reports. The institutional investor owned 22,091 shares of the healthcare conglomerate’s stock at the end of the second quarter. Grandfield & Dodd LLC’s holdings in UnitedHealth Group were worth $3,119,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of UNH. Kanaly Trust Co increased its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Kanaly Trust Co now owns 1,772 shares of the healthcare conglomerate’s stock worth $250,000 after buying an additional 11 shares during the period. First Financial Bank N.A. Trust Division increased its stake in shares of UnitedHealth Group by 0.3% in the second quarter. First Financial Bank N.A. Trust Division now owns 7,847 shares of the healthcare conglomerate’s stock worth $1,108,000 after buying an additional 21 shares during the period. Capital One National Association increased its stake in shares of UnitedHealth Group by 0.3% in the second quarter. Capital One National Association now owns 8,250 shares of the healthcare conglomerate’s stock worth $1,164,000 after buying an additional 25 shares during the period. Osborn Rohs Williams & Donohoe Ltd increased its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Osborn Rohs Williams & Donohoe Ltd now owns 8,984 shares of the healthcare conglomerate’s stock worth $1,269,000 after buying an additional 33 shares during the period. Finally, Capital Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 0.6% in the second quarter. Capital Investment Advisors LLC now owns 6,667 shares of the healthcare conglomerate’s stock worth $941,000 after buying an additional 38 shares during the period. Institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% during midday trading on Friday, reaching $136.66. The company’s stock had a trading volume of 2,568,703 shares. The company has a 50 day moving average of $137.92 and a 200-day moving average of $136.28. The stock has a market capitalization of $130.15 billion, a price-to-earnings ratio of 21.39 and a beta of 0.57. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. The business earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. Equities research analysts predict that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.83%. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.
UNH has been the topic of a number of recent research reports. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research report on Sunday, August 21st. Sanford C. Bernstein restated an “outperform” rating and set a $178.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Royal Bank Of Canada upped their target price on UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 29th. Finally, Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Monday, July 18th. One investment analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.65% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.